Has Thomas Caranasos, MD received payments from drug or device companies?

Yes. Drug and device makers reported $140,738 in general payments to Thomas Caranasos, MD across 363 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thomas Caranasos, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thomas Caranasos, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thomas Caranasos, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Naples, FLNPI 1376715656

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $96,068 of the $140,738 with a category attached, or 68.3%. 27 manufacturers reported payments, led by Baxter Healthcare at 33.4% of the total. 2025 is the largest year on record at $67,805, 4.6 times the $14,608 reported in 2019. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$140,738in general payments, 2019–2025

Across 363 payments — averaging $387.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Baxter Healthcare$47K
Arthrex$32K
Atricure, Inc.$26K
Artivion, Inc.$13K
Edwards Lifesciences$10K
Stryker$3K
plus $9K from 21 others

$6,118in research payments, 2019–2025

Across 3 payments — averaging $2039.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$6K

What the payments were for

Consulting fees$96,06868%
Speaking & faculty fees$24,12517%
Travel & lodging$8,6666%
Food & beverage$11,8798%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Baxter Healthcare	28	$46,995
Arthrex	36	$32,296
Atricure, Inc.	43	$26,087
Artivion, Inc.	70	$13,405
Edwards Lifesciences	47	$9,650
Stryker	4	$3,271
Tricoast Surgical Solutions LLC	32	$2,687
Boston Scientific	3	$1,304
Bolton Medical Inc	19	$1,043
Medtronic(2 entities)	20	$1,037
Abbott	14	$863
Abiomed	14	$846
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	16	$277
W. L. Gore & Associates, Inc.	1	$244
Philips North America LLC	2	$145
Cook Medical LLC	1	$116
Atrium Medical Corporation	2	$108
Biosense Webster, Inc.	1	$87
Kestra Medical Technology Services, Inc.	1	$80
Getinge USA Sales, LLC	2	$67
La Jolla Pharmaceutical Company	1	$24
Johnson & Johnson	1	$22
Kls-martin L.p.	1	$20
United Therapeutics Corporation	1	$19
Corcym Inc	1	$16
Scpharmaceuticals Inc.	1	$16
Cvrx, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$140,738 in reported general payments places this provider in the 95th percentile of 408 thoracic surgery (cardiothoracic vascular surgery) providers in Florida.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Florida →

Medicare billing

Part B allowed, 2024

$81,885

Medicare patients

118

Services billed

228

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metoprolol Succinate	15	$135

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Naples

Brian SolomonNaples$76K
Anthony NunezOrlando$4.8M
Barry WintonLargo$687K
Paul DigiorgiPort Charlotte$666K
John PirrisJacksonville$640K
Jacques FontaineTampa$630K
Andrew ShermanTampa$517K
Rogerio CarrilloHialeah$515K
Daniel O'HairFort Myers$429K
Luis HerreraOrlando$409K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →